Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center - Concepedia

Concepedia

Publication | Open Access

Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center

DOI Full Paper Access

136

Citations

12

References

1993

Year

Rena Vassilopoulou‐Sellin, Beverly Newman, Sarah Taylor, Vincent F. Guinee

Abstract

Hypercalcemia may appear as a frequent complication in patients with cancer at some time during the course of their disease, but its incidence is relatively low.

References

	Year	Citations
Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 cases Donald G. Skinner, Robert B. Colvin, C. Dale Vermillion, Cancer UrologyPathologic StudyGenitourinary CancerRenal CellMedicine	1971	986
PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATION GregoryR. Mundy, D.H. Cove, Roger A Fisken The Lancet UrologyParathyroid HormoneParathyroid DiseasePrimary AldosteronismPrimary Hyperparathyroidism	1980	383
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. Pierre Ruffiè, R. Feld, Salomon Minkin, Journal of Clinical Oncology Retrospective StudyAppropriate Stratification VariablesTumoral PathologyWeight LossMedicine	1989	371
Cancer-Associated Hypercalcemia: Morbidity and Mortality Stuart H. Ralston Annals of Internal Medicine	1990	360
HYPERCALCAEMIA IN HOSPITAL PATIENTS Clinical and Diagnostic Aspects RogerA. Fisken The Lancet Electrolyte DisorderEndocrine DiseaseDiagnosisLaboratory MedicineAdrenal Disease	1981	114
Hypercalcemia in Bronchogenic Carcinoma Richard A. Bender Annals of Internal Medicine Consecutive PatientsHyperthermiaEsophageal CancerMedicineHistopathology	1974	114
Overview of cancer-related hypercalcemia: epidemiology and etiology. Franco M. Muggia PubMed	1990	74
The Incidence and Prognostic Significance of Humoral Hypercalcemia in Renal Cell Carcinoma Huei-Jyh Fahn, Ying-Huei Lee, Ming‐Tsun Chen, The Journal of Urology Retrospective StudyUrologySurgical OncologyRenal FunctionGenitourinary Cancer	1991	59
Changing risk groups for malignant mesothelioma Michael Huncharek Cancer Cancer RiskCancer EpidemiologyMalignant MesotheliomaMedicineEnvironmental Health	1992	48
Endocrine and Nonendocrine Hormone-Producing Tumors. Annals of Internal Medicine Endocrine OncologyNonendocrine Hormone-producing TumorsNeuroendocrine DisorderNeuroendocrine TumorsEndocrinology	1974	43

Page 1